Herein, we demonstrate that HNF1A-AS1 is highly overexpressed in GBM tissues and cells, associates with poor patient survival, by acting as ceRNA for miR-22 and facilitating ENO1, to promote GBM malignant phenotypes. This evidence concerns the gene ENO1 and glioblastoma.